Headlines discussed at LNWM’s Monday morning briefing:
— By mid-Dec. 2020, the FDA is likely to approve distribution of the 95%+ effective Covid-19 vaccine developed by Pfizer and Germany’s BioNTech.
— Closings on existing U.S. home sales rose nearly 27% in Oct. 2020 vs. a year ago; prices have surged on 20%+ drop in supply and record low mortgage rates.
— U.S. retail sales barely increased in Oct. (up 0.3%), after rising 1.6% in Sept.; smallest gain since the recovery started in May.
— Brexit trade talks seem to be getting closer to a final deal before the Dec. 31, 2020 deadline, despite Covid disruptions.
— U.S. weekly unemployment claims rose to 742,000 in mid-Nov.; about 20 million people are getting jobless benefits from state and federal gov’t.
Disclaimer: Clicking on any of the above links will take you away from the Laird Norton Wealth Management web page and to the source page. While we believe the information in these articles is relevant, we cannot guarantee its accuracy or completeness.